Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 82 Records) |
| Query Trace: Neoplasms and FGFR4[original query] |
|---|
| Association between FGFR4 gene polymorphism and high-risk HPV infection cervical cancer. Asian Pacific journal of tropical medicine 2017 Jul 10 (7): 680-684. Li Ya-Ping, Zhang Lin, Zou Yu-Liang, Yu Y |
| Detection of Known and Novel FGFR Fusions in Non-Small Cell Lung Cancer by Comprehensive Genomic Profiling. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 9 14 (1): 54-62. Qin Angel, Johnson Adrienne, Ross Jeffrey S, Miller Vincent A, Ali Siraj M, Schrock Alexa B, Gadgeel Shirish |
| Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations. Acta neuropathologica 2018 6 136 (2): 327-337. Koelsche Christian, Mynarek Martin, Schrimpf Daniel, Bertero Luca, Serrano Jonathan, Sahm Felix, Reuss David E, Hou Yanghao, Baumhoer Daniel, Vokuhl Christian, Flucke Uta, Petersen Iver, Brück Wolfgang, Rutkowski Stefan, Zambrano Sandro Casavilca, Garcia Leon Juan Luis, Diaz Coronado Rosdali Yesenia, Gessler Manfred, Tirado Oscar M, Mora Jaume, Alonso Javier, Garcia Del Muro Xavier, Esteller Manel, Sturm Dominik, Ecker Jonas, Milde Till, Pfister Stefan M, Korshunov Andrey, Snuderl Matija, Mechtersheimer Gunhild, Schüller Ulrich, Jones David T W, von Deimling Andre |
| Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer. Molecular carcinogenesis 2018 4 57 (8): 988-996. Wei Wei, You Zilong, Sun Shanshan, Wang Yuhang, Zhang Xianyu, Pang Da, Jiang Yongdo |
| Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients. BMC cancer 2018 Oct 18 (1): 1038. Chen Lu, Qi Huijie, Zhang Liudi, Li Haixia, Shao Jie, Chen Haifei, Zhong Mingkang, Shi Xiaojin, Ye Ting, Li Qun |
| Functional Analysis of Somatic Mutations Affecting Receptor Tyrosine Kinase Family in Metastatic Colorectal Cancer. Molecular cancer therapeutics 2019 3 18 (6): 1137-1148. Duplaquet Leslie, Figeac Martin, Leprêtre Frédéric, Frandemiche Charline, Villenet Céline, Sebda Shéhérazade, Sarafan-Vasseur Nasrin, Bénozène Mélanie, Vinchent Audrey, Goormachtigh Gautier, Wicquart Laurence, Rousseau Nathalie, Beaussire Ludivine, Truant Stéphanie, Michel Pierre, Sabourin Jean-Christophe, Galateau-Sallé Françoise, Copin Marie-Christine, Zalcman Gérard, De Launoit Yvan, Fafeur Véronique, Tulasne Dav |
| Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma. International journal of environmental research and public health 2019 Dec 17 (1): . Tsay Ming-Dow, Hsieh Ming-Ju, Lee Chia-Yi, Wang Shian-Shiang, Chen Chuan-Shu, Hung Sheng-Chun, Lin Chia-Yen, Yang Shun- |
| Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy. Gynecologic oncology 2020 9 159 (2): 546-553. Yoshimoto Yuya, Sasaki Yasushi, Murata Kazutoshi, Noda Shin-Ei, Miyasaka Yuhei, Hamamoto Junko, Furuya Mio, Hirato Junko, Suzuki Yoshiyuki, Ohno Tatsuya, Tokino Takashi, Oike Takahiro, Nakano Takas |
| FGFR4 Gene Polymorphism Reduces the Risk of Distant Metastasis in Lung Adenocarcinoma in Taiwan. International journal of environmental research and public health 2020 Aug 17 (16): . Li Ju-Pi, Huang Hsien-Cheng, Yang Po-Jen, Chang Chien-Yuan, Chao Yu-Hua, Tsao Thomas Chang-Yao, Huang Hsuan, Hung Yu-Ching, Hsieh Ming-Ju, Yang Shun- |
| FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition. Cancer research and treatment 2020 7 52 (4): 1162-1177. Ye Yanwei, Li Jie, Jiang Dongbao, Li Jingjing, Xiao Chuangfeng, Li Yingze, Han Chao, Zhao Chunl |
| Genetic Characterization of Molecular Targets in Korean Patients with Gastrointestinal Stromal Tumors. Journal of gastric cancer 2020 4 20 (1): 29-40. Park Joonhong, Yoo Han Mo, Sul Hae Jung, Shin Soyoung, Lee Seung Woo, Kim Jeong G |
| Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers. Journal of hematology & oncology 2020 2 13 (1): 13. Coussy F, El Botty R, Lavigne M, Gu C, Fuhrmann L, Briaux A, de Koning L, Dahmani A, Montaudon E, Morisset L, Huguet L, Sourd L, Painsec P, Chateau-Joubert S, Larcher T, Vacher S, Melaabi S, Salomon A Vincent, Marangoni E, Bieche |
| Novel mutations in breast cancer patients from southwestern Colombia. Genetics and molecular biology 2020 11 43 (4): e20190359. Solarte Melissa, Cortes-Urrea Carolina, Franco Nelson Rivera, Barreto Guillermo, Moreno Pedro |
| A comprehensive pan-cancer study of fibroblast growth factor receptor aberrations in Chinese cancer patients. Annals of translational medicine 2020 11 8 (20): 1290. Sun Yi, Li Gao, Zhu Wei, He Qiuyan, Liu Yongchang, Chen Xianshan, Liu Juan, Lin Jing, Han-Zhang Han, Yang Zheng, Lizaso Analyn, Xiang Jianxing, Mao Xinru, Liu Hao, Gao Ya |
| Retraction Notice to: The Cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of Diabetes. Cell metabolism 2020 10 32 (4): 691. Ezzat Shereen, Zheng Lei, Florez Jose C, Stefan Norbert, Mayr Thomas, Hliang Maw Maw, Jablonski Kathleen, Harden Maegan, Stan?áková Alena, Laakso Markku, Haring Hans-Ulrich, Ullrich Axel, Asa Sylvia |
| An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer. Bioscience reports 2020 10 40 (10): . Moazeni-Roodi Abdolkarim, Sarabandi Sahel, Karami Shima, Hashemi Mohammad, Ghavami Sae |
| The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors. Molecular cancer 2020 10 19 (1): 154. Jin Ying, Chen Dong-Liang, Wang Feng, Yang Chao-Pin, Chen Xu-Xian, You Jin-Qi, Huang Jin-Sheng, Shao Yang, Zhu Dong-Qin, Ouyang Yu-Ming, Luo Hui-Yan, Wang Zhi-Qiang, Wang Feng-Hua, Li Yu-Hong, Xu Rui-Hua, Zhang Dong-She |
| Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary. International journal of cancer 2020 Jan . Bochtler Tilmann, Reiling Anna, Endris Volker, Hielscher Thomas, Volckmar Anna-Lena, Neumann Olaf, Kirchner Martina, Budczies Jan, Heukamp Lukas C, Leichsenring Jonas, Allgäuer Michael, Kazdal Daniel, Löffler Harald, Weichert Wilko, Schirmacher Peter, Stenzinger Albrecht, Krämer Alw |
| Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma. JCO precision oncology 2021 5 . Kim Jung, Light Nicholas, Subasri Vallijah, Young Erin L, Wegman-Ostrosky Talia, Barkauskas Donald A, Hall David, Lupo Philip J, Patidar Rajesh, Maese Luke D, Jones Kristine, Wang Mingyi, Tavtigian Sean V, Wu Dongjing, Shlien Adam, Telfer Frank, Goldenberg Anna, Skapek Stephen X, Wei Jun S, Wen Xinyu, Catchpoole Daniel, Hawkins Douglas S, Schiffman Joshua D, Khan Javed, Malkin David, Stewart Douglas |
| Impact of FGFR4 Gene Polymorphism on the Progression of Colorectal Cancer. Diagnostics (Basel, Switzerland) 2021 May 11 (6): . Shiu Bei-Hao, Hsieh Ming-Hong, Ting Wen-Chien, Chou Ming-Chih, Chang Lun-Ching, Huang Chi-Chou, Su Shih-Chi, Yang Shun- |
| Prognosis and Genomic Landscape of Liver Metastasis in Patients With Breast Cancer. Frontiers in oncology 2021 3 11 588136. Tian Chonglin, Liu Sujing, Wang Yongsheng, Song Xianra |
| FGFR4 Gly388Arg Polymorphism Reveals a Poor Prognosis, Especially in Asian Cancer Patients: A Meta-Analysis. Frontiers in oncology 2021 11 11 762528. Kim Jung Han, Jeong Soo Young, Jang Hyun Joo, Park Sung Taek, Kim Hyeong |
| Genomic comparison between cerebrospinal fluid and primary tumor revealed the genetic events associated with brain metastasis in lung adenocarcinoma. Cell death & disease 2021 10 12 (10): 935. Deng Zhiyong, Cui Liang, Li Pansong, Ren Nianjun, Zhong Zhe, Tang Zhi, Wang Lei, Gong Jianwu, Cheng Haofeng, Guan Yanfang, Yi Xin, Xia Xuefeng, Zhou Rongrong, He Zhengw |
| Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrences. Breast cancer research : BCR 2021 1 23 (1): 1. Priedigkeit Nolan, Ding Kai, Horne William, Kolls Jay K, Du Tian, Lucas Peter C, Blohmer Jens-Uwe, Denkert Carsten, Machleidt Anna, Ingold-Heppner Barbara, Oesterreich Steffi, Lee Adrian |
| FGFR4 c.1162G?>?A (p.Gly388Arg) Polymorphism Analysis in Turkish Patients with Retinoblastoma. Journal of oncology 2021 1 2020 9401038. Akdeniz Odemis Demet, Tuncer Seref Bugra, Adamnejad Ghafour Arash, Jabbarli Khariga, Gider Yasemin, Celik Betul, Kuru Turkcan Gozde, Sukruoglu Erdogan Ozge, Kilic Erciyas Seda, Avsar Mukaddes, Kebudi Rejin, Buyukkapu Bay Sema, Tuncer Samuray, Yazici Hul |
| Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer. Scientific reports 2021 Jan 11 (1): 1373. Peng Tao, Sun Yangyang, Lv Zhiwei, Zhang Ze, Su Quanxin, Wu Hao, Zhang Wei, Yuan Wei, Zuo Li, Shi Li, Zhang Li-Feng, Zhou Xiaoli, Mi Yuanyu |
| mTOR pathway gene mutations predict response to immune checkpoint inhibitors in multiple cancers. Journal of translational medicine 2022 6 20 (1): 247. Cheng Lei, Wang Yanan, Qiu Lixin, Chang Yuanyuan, Lu Haijiao, Liu Chenchen, Zhang Bo, Zhou Yan, Bai Hao, Xiong Liwen, Zhong Hua, Nie Wei, Han Baoh |
| Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer. Scientific reports 2022 02 12 (1): 2167. Sitthideatphaiboon Piyada, Teerapakpinyo Chinachote, Korphaisarn Krittiya, Leelayuwatanakul Nophol, Pornpatrananrak Nopporn, Poungvarin Naravat, Chantranuwat Poonchavist, Shuangshoti Shanop, Aporntewan Chatchawit, Chintanapakdee Wariya, Sriuranpong Virote, Vinayanuwattikun Chani |
| Special issue "The advance of solid tumor research in China": FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancer. International journal of cancer 2022 Aug . Gao Guanghui, Cui Longgang, Zhou Fei, Jiang Tao, Wang Wanying, Mao Shiqi, Wu Fengying, Jiang Fangli, Zhang Bei, Bei Ting, Xie Wenchuan, Zhang Cheng, Zhang Hougang, Gao Chan, Zhao Xiaochen, Bai Yuezong, Zhou Caicun, Ren Shengxia |
| Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer. Nature communications 2023 8 14 (1): 5112. Lei-Jie Dai, Ding Ma, Yu-Zheng Xu, Ming Li, Yu-Wei Li, Yi Xiao, Xi Jin, Song-Yang Wu, Ya-Xin Zhao, Han Wang, Wen-Tao Yang, Yi-Zhou Jiang, Zhi-Ming Sh |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: